Europe—heavily criticised by the World Health Organization for its sluggish COVID vaccine rollout—is badly lagging behind in the jabs-in-arms race, according to an AFP tally.
Broadly speaking, the Americans are doing three times better than the 27-nation European Union.
While 11.7 percent of the EU’s population has got a first dose, the US is cresting the 30 percent mark.
Only five percent of EU citizens have had a second dose against 15.9 percent on the other side of the Atlantic.
Although some smaller EU countries like Malta are doing well, giving a job to more than one percent of their populations every day, the rate in the bloc’s four biggest economies—Germany, France, Spain and Italy—is three times slower.
These four countries have given jabs to around 12 percent of their populations, roughly the EU average.
The WHO, which on Thursday slammed the continent’s “unacceptably slow” vaccine roll-out, also includes Israel, Britain, Russia, Turkey and former Soviet Central Asian countries its vast European zone.
The zone overall has given one quarter of the 596 million shots administered around the world although it accounts for just 12 percent of the planet’s population.
That figure was further boosted by Israel, which has topped the vaccination table from the start with three fifths of its population having received at least one dose.
The UK, which is no longer in the EU, has also shone, partly inoculating 45.5 percent of its people, followed by Malta (32.3 percent), Hungary (21.4 percent) and Serbia (21.3 percent).
Other European countries, mainly in the former Eastern Bloc, are advancing much more slowly, like EU members Bulgaria (5.4 percent) and Latvia (6.1 percent) as well as Ukraine (0.6 percent), Moldova (one percent), Montenegro (3.1 percent) and Albania (4.1 percent), who are outside the bloc.
Follow the latest news on the coronavirus (COVID-19) outbreak
© 2021 AFP
Europe badly lags US in jabs-in-arms race (2021, April 1)
retrieved 1 April 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- South African regulator rejects Russia’s COVID-19 vaccine - October 20, 2021
- Second wave of pandemic not receded yet, third wave feared post-Diwali: Maha health minister - October 20, 2021
- WHO chief discusses Covaxin, resumption of AstraZeneca vaccine supplies to COVAX facility with Health Minister Mandaviya - October 20, 2021
- Trivitron Healthcare in collaboration with Diagon- Vanguard Diagnostics launches Diagon’s Coagulation range in India - October 20, 2021
- Breast cancer early detection, screening, and management – what we need to know - October 20, 2021
- WHO’s technical advisory group to meet on Oct 26 to consider Covaxin - October 19, 2021
- 163 oxygen plants set up in MP after shortage during 2nd COVID-19 wave: CM Shivraj Singh Chouhan - October 19, 2021
- India’s R-value below 1 since September, researchers say - October 19, 2021
- Mumbai: Double vaccine jab not mandatory to enter theatres, colleges to reopen with 50% attendance - October 19, 2021
- Daily exercise routine, balanced diet, active lifestyle & quality sleep key to success in personal & professional lives: Experts - October 19, 2021